Trial intelligence / Profile preview

High Dose Dual Therapy vs Non-bismuth Quadruple Therapy for H. pylori

NCT03383003Completed

Sponsor
Chang Gung Memorial Hospital
Start
Mar 2016
Primary completion
May 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of esomeprazole and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Rates of H.pylori eradication. Started Mar 2016; status: completed.

02

Drugs

esomeprazoleamoxicillin
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT03383003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03383003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call